Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older

Andres Forero-Torres; Beata Holkova; Jerome Goldschmidt; Robert Chen; Gregg Olsen; Ralph V. Boccia; Rodolfo E. Bordoni; Jonathan W. Friedberg; Jeff P. Sharman; Maria Corinna Palanca-Wessels; Yinghui Wang; Christopher A. Yasenchak

doi:10.1182/BLOOD-2015-06-644336

Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older

Andres Forero-Torres
, Beata Holkova
, Jerome Goldschmidt
, Robert Chen
, Gregg Olsen
, Ralph V. Boccia
, Rodolfo E. Bordoni
, Jonathan W. Friedberg
, Jeff P. Sharman
, Maria Corinna Palanca-Wessels
, Yinghui Wang
, Christopher A. Yasenchak

University of Alabama at Birmingham
VCU Medical Center
Oncology and Hematology Associates of SW Virginia, Roanoke, VA;
City of Hope National Medical Center
Providence Saint Joseph Medical Center
Center for Cancer and Blood Disorders, Bethesda, MD;
Georgia Cancer Specialists, Marietta, GA;
University of Rochester Medical Center
Willamette University
Seattle Genetics

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Blood
Volume	126
Issue number	26
DOIs	https://doi.org/10.1182/BLOOD-2015-06-644336
State	Published - Dec 24 2015
Externally published	Yes

Disciplines

Medicine and Health Sciences
Endocrinology, Diabetes, and Metabolism
Surgery
Internal Medicine

Access to Document

10.1182/BLOOD-2015-06-644336License: Unspecified

Cite this

@article{f16f3a0d76554676801879e7dc8a6d59,

title = "Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older",

author = "Andres Forero-Torres and Beata Holkova and Jerome Goldschmidt and Robert Chen and Gregg Olsen and Boccia, \{Ralph V.\} and Bordoni, \{Rodolfo E.\} and Friedberg, \{Jonathan W.\} and Sharman, \{Jeff P.\} and Palanca-Wessels, \{Maria Corinna\} and Yinghui Wang and Yasenchak, \{Christopher A.\}",

year = "2015",

month = dec,

day = "24",

doi = "10.1182/BLOOD-2015-06-644336",

language = "American English",

volume = "126",

journal = "Blood",

publisher = "American Society of Hematology",

number = "26",

}

TY - JOUR

T1 - Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older

AU - Forero-Torres, Andres

AU - Holkova, Beata

AU - Goldschmidt, Jerome

AU - Chen, Robert

AU - Olsen, Gregg

AU - Boccia, Ralph V.

AU - Bordoni, Rodolfo E.

AU - Friedberg, Jonathan W.

AU - Sharman, Jeff P.

AU - Palanca-Wessels, Maria Corinna

AU - Wang, Yinghui

AU - Yasenchak, Christopher A.

PY - 2015/12/24

Y1 - 2015/12/24

UR - http://europepmc.org/abstract/MED/26377597

U2 - 10.1182/BLOOD-2015-06-644336

DO - 10.1182/BLOOD-2015-06-644336

M3 - Article

VL - 126

JO - Blood

JF - Blood

IS - 26

ER -

Phase 2 study of frontline brentuximab vedotin monotherapy in Hodgkin lymphoma patients aged 60 years and older

Disciplines

Access to Document

Other files and links

Cite this